Company intelligence / Profile preview
Nutra Pharma Corp
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Nutra Pharma has several commercial over-the-counter pain relief products including Cobroxin, Nyloxin, Pet Pain-Away, Equine Pain-Away, and Luxury Feet. The company has been expanding its manufacturing capabilities for new product launches as of March 2022.
- Therapeutic areas
- ImmunologyNeurology
- Modalities
- Over-the-counter pain relievers
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Third-party distributor for Cell Defender
Beyond the preview
Go deeper on Nutra Pharma Corp.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nutra Pharma Corp.